In mammals, forced expression of active mutants of YAP or TAZ stimulate fibroblast, epithelial and mammary carcinoma cell proliferation and migration, whereas expression of dominant-negative mutants or siRNA silencing inhibits it [48], [49], [50], [51], consistent with our findings. The gene discussed is WWTR1; the disease is breast carcinoma.